Lentivirus vectors using human and simian immunodeficiency virus elements

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 2832-2840

  White, Sarah M ^a   Renda, Matthew ^a,b   Nam, Na Yon ^a   Klimatcheva, Ekaterina ^a   Zhu, Yonghong ^a,b   Fisk, Jennifer ^a   Halterman, Mark ^b   Rimel, Bobbie J ^a   Federoff, Howard ^b   Pandya, Snehal ^a   Rosenblatt, Joseph D ^a,b   Planelles, Vicente ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; GENE DELETION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HELPER VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS EXPRESSION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0033014207     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.2832-2840.1999     Document Type: Article

References (63)

1. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:2581-2585.
2. Banapour, B., M. L. Marthas, R. J. Munn, and P. A. Luciw. 1991. In vitro macrophage tropism ot pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). Virology 183:12-19.
3. Banapour, B., M. L. Marthas, R. A. Ramos, B. L. Lohman, R. E. Unger, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1991. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J. Virol. 65:5798-5805.
4. Berchtold, S., U. Hornung, and C. Aepinus. 1995. The activation domain of simian immunodeficiency virus SIVmac239 Rev protein is structurally and functionally analogous to the HIV-1 Rev activation domain. Virology 211: 285-289.
5. Brewer, G. J., J. R. Torricelli, E. K. Evege, and P. J. Price. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:567-576.
6. Bukrinsky, M. I., and O. K. Haffar. 1997. HIV-1 nuclear import: in search of a leader. Front. Biosci. 2:578-587.
7. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
8. Certo, J. L., B. F. Shook, P. D. Yin, J. T. Snider, and W. S. Hu. 1998. Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J. Virol. 72:5408-5413.
9. Chen, J., E. Ido, M. Jin, T. Kuwata, T. Igarashi, A. Mizuno, Y. Koyanagi, and M. Hayami. 1998. Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells. J. Gen. Virol. 79:741-745.
10. Chong, H., and R. G. Vile. 1996. Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line. Gene Ther. 3:624-629.
11. Corbeau, P., G. Kraus, and F. Wong-Staal. 1998. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system. Gene Ther. 5:99-104.
12. Dillon, P. J., P. Nelbock, A. Perkins, and C. A. Rosen. 1990 Function of the human immunodeficiency virus type 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. J. Virol. 64:4428-4437.
13. Donahue, R. E., S. W. Kessler. D. Bodine, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, R. Moen, et al. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1125-1135.
14. Embretson, J. E., and H. M. Temin. 1987. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:2675-2683.
15. Fletcher, T. M., B. Brichacek, N. Sharova, M. A. Newman, G. Stivahtis, P. M. Sharp, M. Emerman, B. H. Hahn, and M. Stevenson. 1996. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 15:6155-6165.
16. Fritsch, E. F., and H. M. Temin. 1977. Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J. Virol. 24:461-469.
17. Goldman, M. J., P. S. Lee, J. S. Yang, and J. M. Wilson. 1997. Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8:2261-2268.
18. cdc2 activity. J. Virol. 69:6705-6711.
19. Humphries, E. H., and H. M. Temin. 1972. Cell cycle-dependent activation of Rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid. J. Virol. 10:82-87.
20. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
21. Kestler, H. W., D. J. Ringler, D. L. Panicaly, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus load and for development of AIDS. Cell 65:651-662.
22. Kewalramani, V. N., and M. Emerman. 1996. Vpx association with mature core structures of HIV-2. Virology 218:159-168.
23. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66: 2232-2239.
24. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66: 5110-5113.
25. Le, S. Y., M. H. Malim, B. R. Cullen, and J. V. Maizel. 1990. A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res. 18:1613-1623.
26. Liesveld, J. L., S. Rush, M. C. Kempski, A. R. Turner, J. K. Brennan, J. C. Gasson, and C. N. Abboud. 1993. Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Exp. Hematol. 21:1342-1352.
27. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69: 7630-7638.
28. Luciw, P., K. Shaw, R. Unger, V. Planelles, M. Stout, J. Lackner, E. Pratt-Lowe, N. Leung, B. Banapour, and M. Marthas. 1992. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res. Hum. Retroviruses 8:395-402.
29. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400-406.
30. Marthas, M. L., B. Banapour, S. Sutjipto, M. E. Siegel, P. A. Marx, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1989. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18:311-319.
31. Marthas, M. L., R. A. Ramos, B. L. Lohman, K. K. Van Rompay, R. E. Unger, C. J. Miller, B. Banapour, N. C. Pedersen, and P. A. Luciw. 1993. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67:6047-6055.
32. Marthas, M. L., S. Sutjipto, J. Higgins, B. Lohman, J. Torten, P. A. Luciw, P. A. Marx, and N. C. Pedersen. 1990. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:3694-3700.
33. Miller, A. D. 1997. Development and application of retroviral vectors, p. 437-473. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982, 984-986, 989-990.
35. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
36. Mori, K., D. J. Ringler, T. Kodama, and R. C. Desrosiers. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
37. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
38. Naldini, L., V. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
39. Olsen, H. S., S. Beidas, P. Dillon, C. A. Rosen, and A. W. Cochrane. 1991. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element. J. Acquired Immune Defic. Syndr. 4:558-567.
40. Otto, E., A. Jones-Trower, E. F. Vanin, K. Stambaugh, S. N. Mueller, W. F. Anderson, and G. J. McGarrity. 1994. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 5:567-575.
41. Park, I. W., K. Myrick, and J. Sodroski. 1994. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus. J. Acquired Immun. Defic. Syndr. 7:1228-1236.
42. Park, I. W., and J. Sodroski. 1995. Functional analysis of the vpx, vpr, and nef genes of simian immunodeficiency virus. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:335-344.
43. Pasquinelli, A. E., R. K. Ernst, E. Lund, C. Grimm, M. L. Zapp, D. Rekosh, M. L. Hammarskjold, and J. E. Dahlberg. 1997. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16:7500-7510.
44. Planelles, V., F. Bachelerie, J. B. M. Jowett, A. Haislip, Y. Xie, P. Banooni, T. Masuda, and I. S. Y. Chen. 1995. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J. Virol. 69:5883-5889.
45. Planelles, V., A. Haislip, E. S. Withers-Ward, S. A. Stewart, Y. Xie, N. P. Shah, and I. S. Y. Chen. 1995. A new reporter system for detection of retroviral infection. Gene Ther. 2:369-376.
46. Planelles, V., J. B. M. Jowett, Q. X. Li, Y. Xie, B. Hahn, and I. S. Y. Chen. 1996. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:2516-2524.
47. Poeschla, E., J. Gilbert, X. Li, S. Huang, A. Ho, and F. Wong-Staal. 1998. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J. Virol. 72:6527-6536.
48. Poeschla, E. M., F. Wong-Staal, and D. J. Looney. 1998 Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:354-357.
49. Poon, B., K. Grovit-Ferbas, S. A. Stewart, and I. S. Y. Chen. 1998. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281:266-269
50. Poon, B., J. B. Jowett, S. A. Stewart, R. W. Armstrong, G. M. Rishton, and I. S. Chen. 1997. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA-alkylating agent nitrogen mustard. J. Virol. 71:3961-3971.
51. Purcell, D. F., C. M. Broscius, E. F. Vanin, C. E. Buckler, A. W. Nienhuis, and M. A. Martin. 1996. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J. Virol. 70:887-897.
52. Rizvi, T. A., and A. T. Panganiban. 1993. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:2681-2688.
53. Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
54. Sharp, P. M., E. Baues, M. Stevenson, M. Emerman, and B. H. Hahn. 1996. Gene acquisition in HIV and SIV. Nature 383:586-587.
55. Shibata, R., H. Sakai, K. Ogawa, A. Ishimoto, and A. Adachi. 1990. Comparative studies on tat mutants of three primate lentiviruses. Arch. Virol. 114:243-250.
56. Stefano, K. A., R. Collman, D. Kolson, J. Hoxie, N. Nathanson, and F. Gonzalez-Scarano. 1993. Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry. J. Virol. 67:6707-6715.
57. Stewart, S. A., B. Poon, J. B. Jowett, and I. S. Chen. 1997. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:5579-5592.
58. Tristem, M., C. Marshall, A. Karpas, and F. Hill. 1992. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J. 11:3405-3412.
59. Vanin, E. F., M. Kaloss, C. Broscius, and A. W. Nienhuis. 1994. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68:4241-4250.
60. Viglianti, G. A., P. L. Sharma, and J. I. Mullins. 1990. Simian immunodeficiency virus displays complex patterns of RNA splicing. J. Virol. 64:4207-4216.
61. Yamamoto, Y., Y. Saito, S. Iida, J. Asano, S. Sone, and A. Adachi. 1997. Functional analysis of vif genes derived from various primate immunodeficiency viruses. Virus Genes 14:195-200.
62. Zou, J. X., and P. A. Luciw. 1996. The requirement for Vif of SIVmac is cell-type dependent. J. Gen. Virol. 77:427-434.
63. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.